Hisamitsu Pharmaceutical Co., Inc. (4530.T) JPX

6,040.00

+0(+0.00%)

Updated at May 08 03:30PM

Currency In JPY

Key Executives

Name	Title	Year Born
Kazuhide Nakatomi	President, Chief Executive Officer & Representative Director	1972
Mitsutoshi Tsuruta	Senior Executive Officer & Head of Sales & Marketing Division of RX	N/A
Kyu Saito	MD, Executive Officer & Director	1963
Shinichi Murayama	Executive Officer of Mgmt. of Internal Audit Division & Domestic Subsidiary Division and Director	1967
Masaya Okuno	Senior Executive Officer & Head of Sales & Marketing Division of OTC	N/A
Nobuo Tsutsumi	Exe. Officer of Legal Affairs, Prod Environment, Reliability Assurance & Compliance and Director	1964
Hidenao Minami	Executive Officer of Public Relations	N/A
Tetsuo Akiyama	Senior Managing Executive Officer, Head of Business Operations & Head of BU	N/A
Kosuke Sugiyama	Senior MD & Exec. Officer of Human Resources & R&D and Corporate Strategy Planning	1952
Naruhito Higo	Managing Exec. Officer & Head of Global Tech. Dev., MN Business Promo. & QA & Pharmacovigilance	N/A

Name

Title

Pay

Year Born

Kazuhide Nakatomi

President, Chief Executive Officer & Representative Director

1972

Mitsutoshi Tsuruta

Senior Executive Officer & Head of Sales & Marketing Division of RX

N/A

Kyu Saito

MD, Executive Officer & Director

1963

Shinichi Murayama

Executive Officer of Mgmt. of Internal Audit Division & Domestic Subsidiary Division and Director

1967

Masaya Okuno

Senior Executive Officer & Head of Sales & Marketing Division of OTC

N/A

Nobuo Tsutsumi

Exe. Officer of Legal Affairs, Prod Environment, Reliability Assurance & Compliance and Director

1964

Hidenao Minami

Executive Officer of Public Relations

N/A

Tetsuo Akiyama

Senior Managing Executive Officer, Head of Business Operations & Head of BU

N/A

Kosuke Sugiyama

Senior MD & Exec. Officer of Human Resources & R&D and Corporate Strategy Planning

1952

Naruhito Higo

Managing Exec. Officer & Head of Global Tech. Dev., MN Business Promo. & QA & Pharmacovigilance

N/A

Description

Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals, quasi-drugs, and medical devices in Japan. The company provides external pain relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; and BUTENALOCK, a remedy for athlete's foot, as well as ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, transdermal analgesic anti-inflammatory drug; patches for female hormone, asthma treatment, and treatment for overactive bladders. In addition, the company manufactures and sells drugs under MOHRUS TAPE, MOHRUS PAP XR, FENTOS Tapes, NEOXY Tapes, Abstral, ALLESAGA Tapes, HARUROPI Tapes, and MENOAID Combipatch. Further, it provides HFT-290, a transdermal patch for cancer pain. The company sells its products in the United States and Asia. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.